Skip to main content

Advertisement

SpringerLink
Log in

Half-fluence photodynamic therapy in peripapillary circumscribed choroidal haemangiomas

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the safety and efficacy of half-fluence photodynamic therapy (PDT) as treatment for symptomatic peripapillary circumscribed choroidal haemangiomas (CCHs).

Methods

In this prospective, interventional case series; 11 patients with symptomatic peripapillary CCHs presenting to a single centre were treated with half-fluence PDT using verteporfin 6 mg/m2 with fluence of 25 mJ/cm2 (standard is 50 mJ/cm2) and other standard settings. Patients were evaluated at baseline, four weeks, twelve weeks and twenty-four weeks post-PDT treatment with best corrected visual acuity (BCVA), ultrasonography, spectral domain optical coherence tomography (SD-OCT), visual evoked potential and angiographic studies.

Results

Eleven patients with peripapillary CCHs received half-fluence PDT. The BCVA significantly improved to 0.558 ± 0.118 at four weeks post-treatment (P = 0.014), to 0.494 ± 0.114 at twelve weeks (P = 0.006) and 0.441 ± 0.125 at twenty-four weeks (P = 0.007) from baseline levels of 1.017 ± 0.075 on log MAR scales. Similar improvement was observed in central macular thickness (CMT) of 78.50 ± 13.73 μm (P = 0.001) at four weeks; 114.70 ± 27.73 μm (P = 0.003) at twelve weeks and 174.60 ± 23.13 μm (P = 0.001) at twenty-four weeks post-treatment. A single session of re-treatment was required in 18% (n = 2) of patients which also showed complete resolution at last follow-up. No complications were observed without any significant change in retinal nerve fibre layer (RNFL) thickness at six months follow-up.

Conclusions

Half-fluence PDT can be an effective and safe treatment option for peripapillary CCHs which results in both anatomical and functional improvements with no observable complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Karimi S, Nourinia R, Mashayekhi A (2015) Circumscribed choroidal hemangioma. J Ophthalmic Vis Res 10(3):320–328

    Article  Google Scholar 

  2. Krohn J, Rishi P, Froystein T, Singh AD (2019) Circumscribed choroidal haemangioma: Clinical and topographical features. Br J Ophthalmol

  3. Shields JA, Shields CL (2016) Intraocular tumors. An atlas and textbook. 3rd ed. Lippincott Wolters Kluwer; pp. 247–63

  4. Sanborn GE, Augsburger JJ, Shields JA (1982) Treatment of circumscribed choroidal hemangiomas. Ophthalmology 89:1374–1380

    Article  CAS  Google Scholar 

  5. Humphrey WT (1979) Choroidal hemangioma: response to cryotherapy. Ann Ophthalmol 11:100–104

    CAS  PubMed  Google Scholar 

  6. Schilling H, Sauerwein W, Lommatzsch A (1997) Long term results after low dose ocular irradiation for choproidal hemangioma. Br J Ophthalmol 81:267–273

    Article  CAS  Google Scholar 

  7. Ritland JS, Eide N, Tasujo J (2001) External beam irradiation therapy for choroidal hemangiomas. Visual and anatomical results after a dose of 20-25 Gy. Acta Ophthalmol Scand 79184–186

  8. Hannouche D, Frau E, Desjardins L, Cassoux N, Habrand JL, Offret H (1997) Efficacy of proton therapy in circumscribed choroidal hemangiomas associated with serious retinal detachment. Ophthalmology 104:1780–1784

    Article  CAS  Google Scholar 

  9. Kamal A, Watts AR, Rennie IG (2000) Indocyanine green enhanced transpupillary thermotherapy of circumscribed choroidal hemangioma. Eye 14:701–705

    Article  Google Scholar 

  10. Singh AD, Kaiser PK, Sears JE, Gupta M, Rundle PA, Rennie IG (2004) Photodynamic therapy of circumscribed choroidal haemangioma. Br J Ophthalmol 88:1414–1418

    Article  CAS  Google Scholar 

  11. Porrini G, Giovannini A, Amato G, Ioni A, Pantanetti M (2003) Photodynamic therapy of circumscribed choroidal haemangioma. Ophthalmology 110:674–680

    Article  Google Scholar 

  12. Alkin Z, Perente I, Ozkaya A, Alp D, Agca A, Aygit ED, Korkmaz S, Yazici AT, Demirok A (2014) Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy. Clin Ophthalmol 5(8):685–690

    Article  Google Scholar 

  13. Wong IY, Shi X, Gangwani R, Iu LP, Fung N, Li Q, Ng ALK, Li X. One-year results of half-versus standard-dose photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy.

  14. Singh AD, Kaiser PK, Sears JE, Gupta M, Rundle PA, Rennie IG (2004) Photodynamic therapy of circumscribed choroidal haemangioma. Br J Ophthalmol 88(11):1414–1418

    Article  CAS  Google Scholar 

  15. Boixadera A, García-Arumí J, Martínez-Castillo V, Encinas JL, Elizalde J, Blanco-Mateos G, Caminal J, Capeans C, Armada F, Navea A, Olea JL (2009) Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. Ophthalmology 116(1):100–105

    Article  Google Scholar 

  16. Verbraak FD, Schlingemann RO, de Smet MD, Keunen JE (2006) Single spot PDT in patients with circumscribed choroidal haemangioma and near normal visual acuity. Graefes Arch Clin Exp Ophthalmol 244(9):1178–1182

    Article  CAS  Google Scholar 

  17. Verbraak FD, Schlingemann RO, Keunen JE, de Smet MD (2003) Longstanding symptomatic choroidal hemangioma managed with limited PDT as initial or salvage therapy. Graefes Arch Clin Exp Ophthalmol 241(11):891–898

    Article  CAS  Google Scholar 

  18. Blasi MA, Tiberti AC, Scupola A, Balestrazzi A, Colangelo E, Valente P, Balestrazzi E (2010) Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes. Ophthalmology 117(8):1630–1637

    Article  Google Scholar 

  19. Schmidt-Erfurth UM, Michels S, Kusserow C, Jurklies B, Augustin AJ (2002) Photodynamic therapy for symptomatic choroidal hemangioma: visual and anatomic results. Ophthalmology 109(12):2284–2294

    Article  Google Scholar 

  20. Barbazetto I, Schmidt-Erfurth U (2000) Photodynamic therapy of choroidal hemangioma: two case reports. Graefes Arch Clin Exp Ophthalmol 238:214–221

    Article  CAS  Google Scholar 

  21. Madreperla SA (2001) Choroidal hemangioma treated with photodynamic therapy using verteporfin. Arch Ophthalmol 119:1606–1610

    Article  CAS  Google Scholar 

  22. Robertson DM (2002) Photodynamic therapy for choroidal hemangioma associated with serous retinal detachment. Arch Ophthalmol 120:1155–1161

    Article  Google Scholar 

  23. Di Nicola M, Williams BK Jr, Srinivasan A, Al-Dahmash S, Mashayekhi A, Shields JA et al (2020) Photodynamic therapy (PDT) for Circumscribed choroidal hemangioma in 79 consecutive patients: comparative analysis of factors predictive of visual outcome. Ophthalmol Retina S2468–6530:30171–30178

    Google Scholar 

  24. Landau IM, Steen B, Seregard S (2002) Photodynamic therapy for circumscribed choroidal haemangioma. Acta Ophthalmol Scand 80:531–536

    Article  Google Scholar 

  25. Bernstein PS, Horn RS (2008) Verteporfin photodynamic therapy involving the optic nerve for peripapillary choroidal neovascularization. Retina 28(1):81–84

    Article  Google Scholar 

  26. Stehouwer M, Schlingemann RO, Verbraak FD (2020) High recurrence rate in patients with choroidal hemangioma treated with limited single spot photodynamic therapy during long-term follow-up. Acta Ophthalmol 98(7):679–686

    Article  Google Scholar 

Download references

Acknowledgements

Nil

Funding

The author(s) received no financial support for the research, authorship and/or publication of this article.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Armed Forces Medical College, Pune, 411040, India

    Ashok Kumar, Poninder Kumar & Srikanth Sathagopam

  2. Department of Ophthalmology, Army College of Medical Sciences & Base Hospital, Delhi Cantt, 110010, India

    Ashok Kumar, Sanjay Kumar Mishra & Mayank Jhanawar

  3. Department of Community Medicine, Armed Forces Medical College, Pune, 411040, India

    Arun Gupta

Authors
  1. Ashok Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Poninder Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sanjay Kumar Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mayank Jhanawar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arun Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Srikanth Sathagopam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashok Kumar.

Ethics declarations

Conflict of interest

The Authors declare that there is no conflict of interest.

Ethics approval

Obtained from institutional ethical committee.

Patient’s Consent

Obtained from patient for participation as well as publication of manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kumar, A., Kumar, P., Mishra, S.K. et al. Half-fluence photodynamic therapy in peripapillary circumscribed choroidal haemangiomas. Int Ophthalmol 42, 1605–1612 (2022). https://doi.org/10.1007/s10792-021-02154-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-021-02154-9

Keywords

Search

Navigation